Choose a topic to see what studies found, who they apply to, and useful next steps. Open the study details for limits and safety, and follow the links to read the evidence.
Some THC-containing cannabinoid medicines produce small average reductions in chronic pain compared with placebo. Most trial participants had nerve-related pain; the findings do not apply equally to every pain condition or cannabis product.
What studies found
A review published in 2026 included 25 trials and 2,303 people. Selected THC-containing treatment groups averaged about 0.5–0.8 points more pain relief than placebo on a 0–10 scale.
Who was studied, limits & safety +
Where this evidence applies
Most evidence came from nerve-related pain and specific oral medicines or mouth sprays, studied for 1–6 months.
What remains uncertain
This does not establish the same benefit for arthritis, every back-pain condition, flower, or retail CBD products. Low-THC-to-CBD treatments may not improve pain outcomes; long-term effects need more study.
Safety considerations
Dizziness, sedation, and nausea were more common with the THC-containing treatments studied.
A practical next step A useful goal to discuss: whether an improvement helps you walk, sleep, or do daily activities—not just whether a pain score changes.
BRING THESE QUESTIONS TO YOUR CLINICIAN
Is my pain nerve-related, and do these studies apply to it?
What improvement in daily function would count as worthwhile for me?
How do the potential benefits and side effects compare with my other options?
Sources checked . Educational summary; not a personalized treatment plan.
Small sleep benefit in chronic-pain studies
Sleep: a modest benefit in a specific group.
A review of randomized trials found small sleep improvements among people with chronic pain. That is useful information, but it is not proof that cannabis treats insomnia in everyone.
What studies found
Across 39 trials with 5,100 participants, researchers estimated that about 8 more people out of 100 with chronic pain achieved a meaningful improvement in sleep quality compared with placebo.
Who was studied, limits & safety +
Where this evidence applies
Most participants had chronic pain; 38 of the 39 trials studied oral cannabinoids. Typical follow-up was short: the midpoint was 35 days.
What remains uncertain
The result cannot simply be extended to long-term insomnia without chronic pain, or to every product and way of using it.
Safety considerations
Dizziness, daytime sleepiness, fatigue, nausea, and dry mouth were more common in the trials.
A practical next step Bring a simple sleep diary: bedtime, time to fall asleep, nighttime waking, and next-day alertness. It can make a sleep appointment more useful.
BRING THESE QUESTIONS TO YOUR CLINICIAN
Could pain, sleep apnea, a medicine, or another condition explain my sleep problem?
Does evidence from chronic-pain studies apply to my sleep difficulty?
Which changes in sleep and daytime alertness should we track?
Sources checked . Educational summary; not a personalized treatment plan.
CBD trials show mixed results
Anxiety: promising findings need a closer look.
Some trials of CBD report reduced anxiety, while others do not. CBD research and the effects of THC-containing cannabis should be considered separately.
What studies found
A 2024 review of 11 randomized trials found possible anxiety benefits from CBD, but results often conflicted across studies.
Who was studied, limits & safety +
Where this evidence applies
The studies used different CBD preparations, amounts, study designs, and anxiety conditions. Findings from one setting do not establish benefit for every anxiety disorder.
What remains uncertain
More rigorous, longer studies are needed. Current findings do not establish retail CBD or THC-containing cannabis as a replacement for established anxiety treatment.
Safety considerations
Cannabis can itself cause anxiety, paranoia, or disorientation. Personal and family mental health history matter when discussing risks.
A practical next step Make the conversation specific: panic episodes, worry, sleep, and daily functioning may need different approaches.
BRING THESE QUESTIONS TO YOUR CLINICIAN
What diagnosis best explains my symptoms?
Does the CBD research apply to that diagnosis?
Could THC worsen my symptoms, and what established treatments should we compare?
Sources checked . Educational summary; not a personalized treatment plan.
Guideline-supported use for persistent nausea
Chemotherapy nausea has a clearer clinical role.
Cannabinoids have a specific role in managing chemotherapy-related nausea and vomiting that persists despite standard anti-nausea treatment. This is symptom management, not a treatment for cancer itself.
What studies found
ASCO’s 2024 guideline says cannabis or cannabinoids may help persistent chemotherapy-related nausea and vomiting when added to recommended anti-nausea medicines.
Who was studied, limits & safety +
Where this evidence applies
Prescription dronabinol and nabilone have FDA-approved uses for chemotherapy-related nausea and vomiting. An oncology team can assess whether this option fits a particular treatment plan.
What remains uncertain
Evidence for other cancer symptoms is less settled. Cannabis and cannabinoids have not been established as a cancer cure or a substitute for cancer treatment.
Safety considerations
Your oncology team should check for interactions with cancer medicines and other treatments before any changes.
A practical next step Keep track of when nausea occurs, vomiting episodes, fluids you can keep down, and which prescribed anti-nausea medicines you have used.
BRING THESE QUESTIONS TO YOUR CLINICIAN
Have we optimized my standard anti-nausea treatment?
Would a prescription cannabinoid be relevant to my persistent symptoms?
Could it interact with my cancer treatment or other medicines?
Sources checked . Educational summary; not a personalized treatment plan.
FDA-approved medicine for three conditions
A clear distinction: prescription CBD for specific seizures.
Epidiolex, a purified prescription CBD medicine, is FDA-approved for seizures associated with Lennox–Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex in people aged 1 year and older.
What studies found
Controlled clinical trials support this specific medicine for these diagnoses. Its approval covers a standardized prescription product with medical monitoring.
Who was studied, limits & safety +
Where this evidence applies
The evidence and approved use are tied to the named conditions—not all seizure disorders or every CBD product.
What remains uncertain
Store-bought CBD is not an interchangeable substitute. A specialist needs to assess whether a person’s diagnosis matches the evidence.
Safety considerations
Liver blood tests and a medicine-interaction review are needed. Sleepiness and diarrhea can occur. Do not stop seizure medicines suddenly or change them without your prescriber.
A practical next step Bring the exact diagnosis, a seizure diary, and a complete medicine list to your neurology appointment.
BRING THESE QUESTIONS TO YOUR CLINICIAN
Does my diagnosis match an approved use for prescription CBD?
Could it interact with my current seizure medicines?
Sources checked . Educational summary; not a personalized treatment plan.
Known interactions · practical safety checks
Make a medication review useful and specific.
CBD can change how other medicines work, cause sleepiness, and affect the liver. A medication review helps identify risks that a product label alone cannot answer.
What studies found
FDA safety information identifies liver injury and medicine interactions as real risks. Combining CBD with alcohol or medicines that slow brain activity can increase sedation and injury risk.
Who was studied, limits & safety +
Where this evidence applies
Include prescriptions, nonprescription medicines, vitamins, supplements, alcohol, and any THC or CBD products in your review.
What remains uncertain
A product being described as natural does not establish its safety. Many nonprescription CBD products have not undergone FDA evaluation for effectiveness, quality, or appropriate use.
Safety considerations
Ask a pharmacist or clinician about interactions before adding CBD. Do not change prescribed medicines on your own.
A practical next step A useful first step: bring photographs of the labels and write down what you take and when.
BRING THESE QUESTIONS TO YOUR CLINICIAN
Could CBD or THC change how any of my medicines work?
Would my liver health or other conditions change the risks?
What symptoms or test results would need follow-up?
Sources checked . Educational summary; not a personalized treatment plan.
A helpful distinction: research on a prescription cannabinoid medicine may not apply to a dispensary product. Your clinician can help you understand the difference.
GET TO KNOW THE BASICS
Same plant. Different compounds.
THC and CBD are two cannabinoids found in cannabis. Understanding the distinction is a useful first step.
